Genelux Corporation Reports First Quarter 2025 Financial Results and Provides General Business Updates
Provided By GlobeNewswire
Last update: May 6, 2025
WESTLAKE VILLAGE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the first quarter of 2025 and provided general business updates.
Read more at globenewswire.com
